Literature DB >> 25663246

Trichomonas vaginalis infection: How significant is it in men presenting with recurrent or persistent symptoms of urethritis?

Andrea Ng1, Jonathan D C Ross2.   

Abstract

Persistent or recurrent non-gonococcal urethritis has been reported to affect up to 10-20% of men attending sexual health clinics. An audit was undertaken to review the management of persistent or recurrent non-gonococcal urethritis in men presenting at Whittall Street Clinic, Birmingham, UK. Detection of Trichomonas vaginalis infection was with the newly-introduced nucleic acid amplification test. A total of 43 (8%) of 533 men treated for urethritis re-attended within three months with persistent or recurrent symptoms. Chlamydia trachomatis infection was identified in 13/40 (33%), T. vaginalis in 1/27 (4%) and Mycoplasma genitalium in 6/12 (50%). These findings suggest that the prevalence of T. vaginalis infection remains low in our clinic population and may not contribute significantly to persistent or recurrent non-gonococcal urethritis.
© The Author(s) 2015.

Entities:  

Keywords:  Sexually transmitted infections; Trichomonas vaginalis; audit; men; non-gonococcal urethritis; persistent; recurrent

Mesh:

Year:  2015        PMID: 25663246     DOI: 10.1177/0956462415571372

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  3 in total

1.  Costing of National STI Program Implementation for the Global STI Control Strategy for the Health Sector, 2016-2021.

Authors:  Eline L Korenromp; Teodora Wi; Stephen Resch; John Stover; Nathalie Broutet
Journal:  PLoS One       Date:  2017-01-27       Impact factor: 3.240

Review 2.  Is There Any Relationship between Trichomonas vaginalis Infection and Male Urethritis Risk? A Systematic Review and Meta-Analysis.

Authors:  Hajar Ziaei Hezarjaribi; Reza Saberi; Mahdi Fakhar; Najmeh Sadeghian
Journal:  Interdiscip Perspect Infect Dis       Date:  2022-09-06

Review 3.  Management of non-gonococcal urethritis.

Authors:  Harald Moi; Karla Blee; Patrick J Horner
Journal:  BMC Infect Dis       Date:  2015-07-29       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.